ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846
-A A +A

R and D in Pharma Industry in Context of Biotech Commercialisation

R and D capabilities in modern biology have become a necessary prerequisite for enterprises that venture to exploit Biotechnology (BT) commercially. In this paper an attempt is made to study the capabilities in R and D in the Indian pharmaceutical industry in terms of magnitude and direction. An analysis based on 33 companies shows that some diversified companies are equally equipped to commercialise biotechnology as most of the dedicated biotech companies but this requires an organised effort by all interested parties, namely, research organisations, the state and the industry.

Subscribers please login to access full text of the article.

New 3 Month Subscription
to Digital Archives at

826for India

$50for overseas users

Get instant access to the complete EPW archives

Subscribe now

Comments

(-) Hide

EPW looks forward to your comments. Please note that comments are moderated as per our comments policy. They may take some time to appear. A comment, if suitable, may be selected for publication in the Letters pages of EPW.

Back to Top